Literature DB >> 20393455

Does tacrolimus, in comparison with sirolimus, increase mycophenolic acid exposure in kidney transplant recipients?

N Picard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393455      PMCID: PMC3223599          DOI: 10.1038/clpt.2010.16

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  An ex vivo model to study the intestinal biotransformation of immunosuppressives.

Authors:  F Braun; U Christians; S Laabs; K Elias; M Shipkova; E Schütz; B Ringe
Journal:  Transplant Proc       Date:  2000-11       Impact factor: 1.066

2.  Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.

Authors:  T van Gelder; J Klupp; M J Barten; U Christians; R E Morris
Journal:  Ther Drug Monit       Date:  2001-04       Impact factor: 3.681

3.  Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.

Authors:  F Braun; H Schöcklmann; E Ziegler; U Kunzendorf; V W Armstrong; L Renders
Journal:  Clin Pharmacol Ther       Date:  2009-07-15       Impact factor: 6.875

4.  The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.

Authors:  N Picard; S W Yee; J-B Woillard; Y Lebranchu; Y Le Meur; K M Giacomini; P Marquet
Journal:  Clin Pharmacol Ther       Date:  2009-11-04       Impact factor: 6.875

5.  Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.

Authors:  Yasuaki Mino; Takafumi Naito; Tomomi Matsushita; Atsushi Otsuka; Tomomi Ushiyama; Seiichiro Ozono; Akira Hishida; Yoshiyuki Kagawa; Junichi Kawakami
Journal:  Ther Drug Monit       Date:  2008-12       Impact factor: 3.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.